These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30981875)

  • 41. Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine.
    Wang RW; Liu L; Cheng H
    Drug Metab Dispos; 1996 Jul; 24(7):786-91. PubMed ID: 8818577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes.
    Crewe HK; Ellis SW; Lennard MS; Tucker GT
    Biochem Pharmacol; 1997 Jan; 53(2):171-8. PubMed ID: 9037249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple cytochrome P450 isoforms are involved in the generation of a pharmacologically active thiol metabolite, whereas paraoxonase 1 and carboxylesterase 1 catalyze the formation of a thiol metabolite isomer from ticlopidine.
    Kim MJ; Jeong ES; Park JS; Lee SJ; Ghim JL; Choi CS; Shin JG; Kim DH
    Drug Metab Dispos; 2014 Jan; 42(1):141-52. PubMed ID: 24170778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis.
    Vizeli P; Straumann I; Holze F; Schmid Y; Dolder PC; Liechti ME
    Sci Rep; 2021 May; 11(1):10851. PubMed ID: 34035391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.
    Kharasch ED; Thummel KE
    Anesthesiology; 1993 Oct; 79(4):795-807. PubMed ID: 8214760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In-vitro cytotoxicity of ET-743 (Trabectedin, Yondelis), a marine anti-cancer drug, in the Hep G2 cell line: influence of cytochrome P450 and phase II inhibition, and cytochrome P450 induction.
    Brandon EF; Meijerman I; Klijn JS; den Arend D; Sparidans RW; Lázaro LL; Beijnen JH; Schellens JH
    Anticancer Drugs; 2005 Oct; 16(9):935-43. PubMed ID: 16162970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of human cytochrome P450 3A4 in the metabolism of DA-8159, a new erectogenic.
    Ji HY; Lee HW; Kim HH; Kim DS; Yoo M; Kim WB; Lee HS
    Xenobiotica; 2004; 34(11-12):973-82. PubMed ID: 15801542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The quantitation of 2-oxo-3-hydroxy lysergic acid diethylamide (O-H-LSD) in human urine specimens, a metabolite of LSD: comparative analysis using liquid chromatography-selected ion monitoring mass spectrometry and liquid chromatography-ion trap mass spectrometry.
    Poch GK; Klette KL; Anderson C
    J Anal Toxicol; 2000 Apr; 24(3):170-9. PubMed ID: 10774536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions.
    Prakash C; Kamel A; Cui D; Whalen RD; Miceli JJ; Tweedie D
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):35S-42S. PubMed ID: 10771452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Halofantrine metabolism in microsomes in man: major role of CYP 3A4 and CYP 3A5.
    Baune B; Flinois JP; Furlan V; Gimenez F; Taburet AM; Becquemont L; Farinotti R
    J Pharm Pharmacol; 1999 Apr; 51(4):419-26. PubMed ID: 10385214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11.
    Nielsen LM; Holm NB; Olsen L; Linnet K
    Drug Test Anal; 2016 Aug; 8(8):792-800. PubMed ID: 26360322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of propofol on human hepatic microsomal cytochrome P450 activities.
    McKillop D; Wild MJ; Butters CJ; Simcock C
    Xenobiotica; 1998 Sep; 28(9):845-53. PubMed ID: 9764927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of dolasetron. Comparison with other indole-containing 5-HT3 antagonists.
    Sanwald P; David M; Dow J
    Drug Metab Dispos; 1996 May; 24(5):602-9. PubMed ID: 8723743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
    Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes.
    AlRabiah H; Ahad A; Mostafa GAE; Al-Jenoobi FI
    Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):707-713. PubMed ID: 29744741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of cytochrome P450 inhibition assays using human liver microsomes by a cassette analysis /LC-MS/MS.
    Zambon S; Fontana S; Kajbaf M
    Drug Metab Lett; 2010 Aug; 4(3):120-8. PubMed ID: 20642444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stereoselective interaction between tetrahydropalmatine enantiomers and CYP enzymes in human liver microsomes.
    Sun SY; Wang YQ; Li LP; Wang L; Zeng S; Zhou H; Jiang HD
    Chirality; 2013 Jan; 25(1):43-7. PubMed ID: 23001793
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxidation of 3-aminobenzanthrone, a human metabolite of carcinogenic environmental pollutant 3-nitrobenzanthrone, by cytochromes P450 - similarity between human and rat enzymes.
    Mizerovska J; Dracinska H; Arlt VM; Schmeiser HH; Frei E; Stiborova M
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():52-9. PubMed ID: 20027145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s.
    Kim JH; Kim HS; Kong TY; Lee JY; Kim JY; In MK; Lee HS
    J Pharm Biomed Anal; 2016 Feb; 119():50-8. PubMed ID: 26641707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.